Replies to post #758189 on NorthWest Biotherapeutics Inc (NWBO)

[KRISGO]

Regardless, it sounds like a deal to buy Oncovir's Polyc-ICLC for trial use which would come with an agreement on commercial terms if things go well. I fail to see why the supposed -L + Poly trial would depend on the MAA outcome.

In my opinion, MAA approval is crucial right now because, for any partnerships or new trials, the big question is where we’ll get the funding from. If we don’t receive the approval, who will trust NWBO enough to provide funding?